Trinity Biotech
TRIB
21 hedge funds and large institutions have $1.66M invested in Trinity Biotech in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
255% more capital invested
Capital invested by funds: $468K → $1.66M (+$1.19M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
3.77% more ownership
Funds ownership: 0.01% → 3.78% (+3.8%)
13% less funds holding
Funds holding: 24 → 21 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$1.2M |
| 2 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$42K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$17.2K |
| 4 |
WN
Williams & Novak
Westlake Village,
California
|
+$2.53K |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$2.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$37K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$27.8K |
| 3 |
Renaissance Technologies
New York
|
-$13.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$10K |
| 5 |
Morgan Stanley
New York
|
-$1.23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| – | -$27.8K | -1,385 | Closed |
|
|
TSS
27
Two Sigma Securities
New York
| – | -$10K | -585 | Closed |
|
|
28
Morgan Stanley
New York
| – | -$1.23K | -72 | Closed |
|
|
GI
29
GAMMA Investing
Foster City,
California
| – | -$367 | -21 | Closed |
|
30
Simplex Trading
Chicago,
Illinois
| – | -$120 | -6 | -86% |
|
TRIB Hedge Fund Activity: Q2 2025 in Review
21 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q2 2025, worth a combined $1.66M — up 255% from $468K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TRIB and 2 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $1.2M. The largest seller was HRT Financial, exiting entirely with an estimated $37K sold.
- 21 institutional investors held Trinity Biotech (TRIB) as of Q2 2025, down from 24 in Q1 2025.
- Funds reported $1.66M of Trinity Biotech stock for Q2 2025, up 255% quarter-over-quarter.
- 2 funds opened new Trinity Biotech positions in Q2 2025 and 5 closed out, a net change of -3 holders.
- The largest Trinity Biotech buyer in Q2 2025 was Perceptive Advisors, an estimated $1.2M added.
- The largest Trinity Biotech seller in Q2 2025 was HRT Financial, an estimated $37K sold.
Based on aggregated 13F filings for Q2 2025.